Buclizine

Buclizine
Clinical data
AHFS/Drugs.com	Micromedex Detailed Consumer Information
ATC code	R06AE01 (WHO) ;
Identifiers
	IUPAC name (RS)-1-[(4-chlorophenyl)- phenyl-methyl]-4- [(4-tert-butylphenyl) methyl] piperazine;
CAS Number	82-95-1 ;
PubChem CID	6729;
IUPHAR/BPS	7134;
DrugBank	DB00354 ;
ChemSpider	6473 ;
UNII	0C94V6X681;
ChEBI	CHEBI:3205 ;
ChEMBL	ChEMBL1201271 ;
CompTox Dashboard (EPA)	DTXSID0022694 ;
ECHA InfoCard	100.001.317
Chemical and physical data
Formula	C28H33ClN2
Molar mass	433.04 g·mol−1
3D model (JSmol)	Interactive image;
Chirality	Racemic mixture
	SMILES Clc1ccc(cc1)C(c2ccccc2)N3CCN(CC3)Cc4ccc(cc4)C(C)(C)C;
	InChI InChI=1S/C28H33ClN2/c1-28(2,3)25-13-9-22(10-14-25)21-30-17-19-31(20-18-30)27(23-7-5-4-6-8-23)24-11-15-26(29)16-12-24/h4-16,27H,17-21H2,1-3H3 ; Key:MOYGZHXDRJNJEP-UHFFFAOYSA-N ;
	(what is this?) (verify)

Buclizine is an antihistamine and anticholinergic of the diphenylmethylpiperazine group. It is considered to be an antiemetic, similar to meclizine.^[1]

In the United Kingdom, buclizine is one of three drugs contained in Migraleve tablets, marketed by McNeil Healthcare for migraines.^[2]

References

^ Mostafa GA, Al-Badr AA (2011). Buclizine. Profiles of Drug Substances, Excipients and Related Methodology. Vol. 36. pp. 1–33. doi:10.1016/B978-0-12-387667-6.00001-4. ISBN 9780123876676. PMID 22469258. {{cite book}}: |journal= ignored (help)
^ Behrendt WA, Cserepes J (1985). "Acute toxicity and analgesic action of a combination of buclizine, codeine and paracetamol ('Migraleve') in tablet and suppository form in rats". Pharmatherapeutica. 4 (5): 322–31. PMID 4070325.

This drug article relating to the respiratory system is a stub. You can help Wikipedia by expanding it.